1. Young A, Denaro M . Roles of amylin in diabetes and in regulation of nutrient load.Nutrition 1998;14: 524–527.

   Article CAS PubMed  Google Scholar 

2. Lutz TA, Geary N, Szabady MM, Del Prete E, Scharrer E . Amylin decreases meal size in rats.Physiol Behav 1995;58: 1197–1202.

   Article CAS PubMed  Google Scholar 

3. Boyle CN, Lutz TA . Amylinergic control of food intake in lean and obese rodents.Physiol Behav 2011;105: 129–137.

   Article CAS PubMed  Google Scholar 

4. Hansen FC, Bueter M, Theis N, Lutz TA, Paulsen S, Dalboge Let al. Hypertrophy dependent doubling of L-cells in Roux-en-Y gastric bypass operated rats.Plos One 2013;8: e65696.

   Article CAS PubMed PubMed Central  Google Scholar 

5. Ezcurra M, Reimann F, Gribble FM, Emery E . Molecular mechanisms of incretin hormone secretion.Curr Opin Pharmacol 2013;13: 922–927.

   Article CAS PubMed PubMed Central  Google Scholar 

6. Chambers AP, Jessen L, Ryan KK, Sisley S, Wilson-Perez HE, Stefater MAet al. Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats.Gastroenterology 2011;141: 950–958.

   Article CAS PubMed  Google Scholar 

7. Jorgensen NB, Dirksen C, Bojsen-Moller KN, Jacobsen SH, Worm D, Hansen DLet al. Exaggerated glucagon-like peptide 1 response is important for improved beta-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.Diabetes 2013;62: 3044–3052.

   Article PubMed PubMed Central CAS  Google Scholar 

8. le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, Prasad Vet al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.Ann Surg 2006;243: 108–114.

   Article PubMed  Google Scholar 

9. Mumphrey MB, Patterson LM, Zheng H, Berthoud HR . Roux-en-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin-expressing enteroendocrine cells in rats.Neurogastroenterol Motil 2013;25: e70–e79.

   Article CAS PubMed  Google Scholar 

10. Bueter M, Lowenstein C, Olbers T, Wang M, Cluny NL, Bloom SRet al. Gastric bypass increases energy expenditure in rats.Gastroenterology 2010;138: 1845–1853.

    Article PubMed  Google Scholar 

11. Osto E, Doytcheva P, Corteville C, Bueter M, Dorig C, Stivala Set al. Rapid and body weight-independent improvement of endothelial and HDL function after Roux-en-Y gastric bypass: role of glucagon-like peptide-1.Circulation 2015; (131: 871–878.

    Article CAS PubMed  Google Scholar 

12. Rinaman L . A functional role for central glucagon-like peptide-1 receptors in lithium chloride-induced anorexia.Am J Physiol 1999;277 (5 Pt 2): R1537–R1540.

    CAS PubMed  Google Scholar 

13. Kanoski SE, Fortin SM, Arnold M, Grill HJ, Hayes MR . Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.Endocrinology 2011;152: 3103–3112.

    Article CAS PubMed PubMed Central  Google Scholar 

14. Hisadome K, Reimann F, Gribble FM, Trapp S. CCK . stimulation of GLP-1 neurons involves alpha1-adrenoceptor-mediated increase in glutamatergic synaptic inputs.Diabetes 2011;60: 2701–2709.

    Article CAS PubMed PubMed Central  Google Scholar 

15. Richards P, Parker HE, Adriaenssens AE, Hodgson JM, Cork SC, Trapp Set al. Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model.Diabetes 2014;63: 1224–1233.

    Article CAS PubMed  Google Scholar 

16. Barrera JG, Sandoval DA, D’Alessio DA, Seeley RJ . GLP-1 and energy balance: an integrated model of short-term and long-term control.Nat Rev Endocrinol 2011;7: 507–516.

    Article CAS PubMed PubMed Central  Google Scholar 

17. Lutz TA . The role of amylin in the control of energy homeostasis.Am J Physiol Regul Integr Comp Physiol 2010;298: R1475–R1484.

    Article CAS PubMed  Google Scholar 

18. Geary N . A new way of looking at eating.Am J Physiol Regul Integr Comp Physiol 2005;288: R1444–R1446.

    Article CAS PubMed  Google Scholar 

19. Lutz TA, Geary N Gastrointestinal factors in Appetite and Food Research—Animal Research. In: Harris R, Mattes R (eds).Appetite and Food Intake: Behavioral and Physiological Consideration. CRC Press, Taylor & Francis Group: Boca Raton, London, New York, 2008, pp 163–186.

20. Reidelberger RD, Arnelo U, Granqvist L, Permert J . Comparative effects of amylin and cholecystokinin on food intake and gastric emptying in rats.Am J Physiol Regul Integr Comp Physiol 2001;280: R605–R611.

    Article CAS PubMed  Google Scholar 

21. Reidelberger RD, Kelsey L, Heimann D . Effects of amylin-related peptides on food intake, meal patterns, and gastric emptying in rats.Am J Physiol Regul Integr Comp Physiol 2002;282: R1395–R1404.

    Article CAS PubMed  Google Scholar 

22. Rushing PA, Seeley RJ, Air EL, Lutz TA, Woods SC . Acute 3rd-ventricular amylin infusion potently reduces food intake but does not produce aversive consequences.Peptides 2002;23: 985–988.

    Article CAS PubMed  Google Scholar 

23. Ruttimann EB, Arnold M, Hillebrand JJ, Geary N, Langhans W . Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms.Endocrinology 2009;150: 1174–1181.

    Article CAS PubMed  Google Scholar 

24. Chelikani PK, Haver AC, Reidelberger RD . Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats.Am J Physiol Regul Integr Comp Physiol 2005;288: R1695–R1706.

    Article CAS PubMed  Google Scholar 

25. Mollet A, Gilg S, Riediger T, Lutz TA . Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats.Physiol Behav 2004;81: 149–155.

    Article CAS PubMed  Google Scholar 

26. Williams DL, Baskin DG, Schwartz MW . Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety.Endocrinology 2009;150: 1680–1687.

    Article CAS PubMed  Google Scholar 

27. Ruttimann EB, Arnold M, Geary N, Langhans W . GLP-1 antagonism with exendin (9-39) fails to increase spontaneous meal size in rats.Physiol Behav 2010;100: 291–296.

    Article CAS PubMed  Google Scholar 

28. Steinert RE, Schirra J, Meyer-Gerspach AC, Kienle P, Fischer H, Schulte Fet al. Effect of glucagon-like peptide-1 receptor antagonism on appetite and food intake in healthy men.Am J Clin Nutr 2014;100: 514–523.

    Article CAS PubMed  Google Scholar 

29. Melhorn SJ, Tyagi V, Smeraglio A, Roth CL, Schur EA . Initial evidence that GLP-1 receptor blockade fails to suppress postprandial satiety or promote food intake in humans.Appetite 2014;82: 85–90.

    Article PubMed PubMed Central  Google Scholar 

30. Lutz TA, Mollet A, Rushing PA, Riediger T, Scharrer E . The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema/nucleus of the solitary tract (AP/NTS) lesioned rats.Int J Obes Relat Metab Disord 2001;25: 1005–1011.

    Article CAS PubMed  Google Scholar 

31. Arnelo U, Permert J, Adrian TE, Larsson J, Westermark P, Reidelberger RD . Chronic infusion of islet amyloid polypeptide causes anorexia in rats.Am J Physiol 1996;271 (6 Pt 2): R1654–R1659.

    CAS PubMed  Google Scholar 

32. Mells JE, Fu PP, Sharma S, Olson D, Cheng L, Handy JAet al. Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet.Am J Physiol Gastrointest Liver Physiol 2012;302: G225–G235.

    Article CAS PubMed  Google Scholar 

33. Rowland NE, Crews EC, Gentry RM . Comparison of Fos induced in rat brain by GLP-1 and amylin.Regul Pept 1997;71: 171–174.

    Article CAS PubMed  Google Scholar 

34. Zuger D, Forster K, Lutz TA, Riediger T . Amylin and GLP-1 target different populations of area postrema neurons that are both modulated by nutrient stimuli.Physiol Behav 2013;112–113: 61–69.

    Article PubMed CAS  Google Scholar 

35. Baumgartner I, Pacheco-Lopez G, Ruttimann EB, Arnold M, Asarian L, Langhans Wet al. Hepatic-portal vein infusions of glucagon-like peptide-1 reduce meal size and increase c-Fos expression in the nucleus tractus solitarii, area postrema and central nucleus of the amygdala in rats.J Neuroendocrinol 2010;22: 557–563.

    Article CAS PubMed  Google Scholar 

36. Riediger T, Zuend D, Becskei C, Lutz TA . The anorectic hormone amylin contributes to feeding-related changes of neuronal activity in key structures of the gut-brain axis.Am J Physiol Regul Integr Comp Physiol 2004;286: R114–R122.

    Article CAS PubMed  Google Scholar 

37. Mack CM, Soares CJ, Wilson JK, Athanacio JR, Turek VF, Trevaskis JLet al. Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight.Int J Obes 2010;34: 385–395.

    Article CAS  Google Scholar 

38. Lutz TA, Senn M, Althaus J, Del Prete E, Ehrensperger F, Scharrer E . Lesion of the area postrema/nucleus of the solitary tract (AP/NTS) attenuates the anorectic effects of amylin and calcitonin gene-related peptide (CGRP) in rats.Peptides 1998;19: 309–317.

    Article CAS PubMed  Google Scholar 

39. Potes CS, Turek VF, Cole RL, Vu C, Roland BL, Roth JDet al. Noradrenergic neurons of the area postrema mediate amylin’s hypophagic action.Am J Physiol Regul Integr Comp Physiol 2010;299: R623–R631.

    Article CAS PubMed  Google Scholar 

40. Edwards GL, Gedulin BR, CJ, Dilts RP, CCM, Young A . Area postrem (AP)-lesions block the regulation of gastric emptying by amylin.Neurogastroenterol Motil 1998;10.

41. Wickbom J, Herrington MK, Permert J, Jansson A, Arnelo U . Gastric emptying in response to IAPP and CCK in rats with subdiaphragmatic afferent vagotomy.Regul Pept 2008;148: 21–25.

    Article CAS PubMed  Google Scholar 

42. Lutz TA, Althaus J, Rossi R, Scharrer E . Anorectic effect of amylin is not transmitted by capsaicin-sensitive nerve fibers.Am J Physiol 1998;274 (6 Pt 2): R1777–R1782.

    CAS PubMed  Google Scholar 

43. Lutz TA, Del Prete E, Scharrer E . Reduction of food intake in rats by intraperitoneal injection of low doses of amylin.Physiol Behav 1994;55: 891–895.

    Article CAS PubMed  Google Scholar 

44. Lutz TA, Del Prete E, Scharrer E . Subdiaphragmatic vagotomy does not influence the anorectic effect of amylin.Peptides 1995;16: 457–462.

    Article CAS PubMed  Google Scholar 

45. Mietlicki-Baase EG, Hayes MR . Amylin activates distributed CNS nuclei to control energy balance.Physiol Behav 2014;136: 39–46.

    Article CAS PubMed  Google Scholar 

46. Lutz TA, Tschudy S, Rushing PA, Scharrer E . Amylin receptors mediate the anorectic action of salmon calcitonin (sCT).Peptides 2000;21: 233–238.

    Article CAS PubMed  Google Scholar 

47. Mietlicki-Baase EG, Rupprecht LE, Olivos DR, Zimmer DJ, Alter MD, Pierce RCet al. Amylin receptor signaling in the ventral tegmental area is physiologically relevant for the control of food intake.Neuropsychopharmacology 2013;38: 1685–1697.

    Article CAS PubMed PubMed Central  Google Scholar 

48. Banks WA, Kastin AJ . Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin.Peptides 1998;19: 883–889.

    Article CAS PubMed  Google Scholar 

49. Banks WA, Kastin AJ, Maness LM, Huang W, Jaspan JB . Permeability of the blood-brain barrier to amylin.Life Sci 1995;57: 1993–2001.

    Article CAS PubMed  Google Scholar 

50. Bailey R, Walker C, Ferner A, Loomes K, Prijic G, Halim Aet al. Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes.Br J Pharmacol 2012;166: 151–167.

    Article CAS PubMed PubMed Central  Google Scholar 

51. Punjabi M, Arnold M, Ruttimann E, Graber M, Geary N, Pacheco-Lopez Get al. Circulating glucagon-like peptide-1 (GLP-1) inhibits eating in male rats by acting in the hindbrain and without inducing avoidance.Endocrinology 2014;155: 1690–1699.

    Article PubMed CAS  Google Scholar 

52. Bailey RJ, Walker CS, Ferner AH, Loomes KM, Prijic G, Halim Aet al. Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes.Br J Pharmacol 2012;166: 151–167.

    Article CAS PubMed PubMed Central  Google Scholar 

53. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson Net al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor.Nature 1998;393: 333–339.

    Article CAS PubMed  Google Scholar 

54. Hay DL, Christopoulos G, Christopoulos A, Poyner DR, Sexton PM . Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes.Mol Pharmacol 2005;67: 1655–1665.

    Article CAS PubMed  Google Scholar 

55. Sexton PM, Paxinos G, Kenney MA, Wookey PJ, Beaumont K .In vitro autoradiographic localization of amylin binding sites in rat brain.Neuroscience 1994;62: 553–567.

    Article CAS PubMed  Google Scholar 

56. Becskei C, Riediger T, Zund D, Wookey P, Lutz TA . Immunohistochemical mapping of calcitonin receptors in the adult rat brain.Brain Res 2004;1030: 221–233.

    Article CAS PubMed  Google Scholar 

57. Barth SW, Riediger T, Lutz TA, Rechkemmer G . Peripheral amylin activates circumventricular organs expressing calcitonin receptor a/b subtypes and receptor-activity modifying proteins in the rat.Brain Res 2004;997: 97–102.

    Article CAS PubMed  Google Scholar 

58. Ueda T, Ugawa S, Saishin Y, Shimada S . Expression of receptor-activity modifying protein (RAMP) mRNAs in the mouse brain.Brain Res Mol Brain Res 2001;93: 36–45.

    Article CAS PubMed  Google Scholar 

59. Liberini CG, Boyle CN, Cifani C, Venniro M, Hope BT, Lutz TA . Amylin receptor components and the leptin receptor are co-expressed in single rat area postrema neurons.Eur J Neurosci 2016;43: 653–661.

    Article PubMed  Google Scholar 

60. Riediger T, Schmid HA, Lutz T, Simon E . Amylin potently activates AP neurons possibly via formation of the excitatory second messenger cGMP.Am J Physiol Regul Integr Comp Physiol 2001;281: R1833–R1843.

    Article CAS PubMed  Google Scholar 

61. Potes CS, Boyle CN, Wookey PJ, Riediger T, Lutz TA . Involvement of the extracellular signal-regulated kinase 1/2 signaling pathway in amylin’s eating inhibitory effect.Am J Physiol Regul Integr Comp Physiol 2012;302: R340–R351.

    Article CAS PubMed  Google Scholar 

62. Braegger FE, Asarian L, Dahl K, Lutz TA, Boyle CN . The role of the area postrema in the anorectic effects of amylin and salmon calcitonin: behavioral and neuronal phenotyping.Eur J Neurosci 2014;40: 3055–3066.

    Article PubMed  Google Scholar 

63. Ronveaux CC, de Lartigue G, Raybould HE . Ability of GLP-1 to decrease food intake is dependent on nutritional status.Physiol Behav 2014;135: 222–229.

    Article CAS PubMed PubMed Central  Google Scholar 

64. Michel S, Becskei C, Erguven E, Lutz TA, Riediger T . Diet-derived nutrients modulate the effects of amylin on c-Fos expression in the area postrema and on food intake.Neuroendocrinology 2007;86: 124–135.

    Article CAS PubMed  Google Scholar 

65. Wielinga PY, Alder B, Lutz TA . The acute effect of amylin and salmon calcitonin on energy expenditure.Physiol Behav 2007;91: 212–217.

    Article CAS PubMed  Google Scholar 

66. Wielinga PY, Löwenstein C, Alder B, Lutz TA . Effect of peripheral and central amylin on energy expenditure and body temperature.Appetite 2008;91: 409.

    Google Scholar 

67. Fernandes-Santos C, Zhang Z, Morgan DA, Guo DF, Russo AF, Rahmouni K . Amylin acts in the central nervous system to increase sympathetic nerve activity.Endocrinology 2013;154: 2481–2488.

    Article CAS PubMed PubMed Central  Google Scholar 

68. Osaka T, Tsukamoto A, Koyama Y, Inoue S . Central and peripheral administration of amylin induces energy expenditure in anesthetized rats.Peptides 2008;29: 1028–1035.

    Article CAS PubMed  Google Scholar 

69. Wielinga PY, Lowenstein C, Muff S, Munz M, Woods SC, Lutz TA . Central amylin acts as an adiposity signal to control body weight and energy expenditure.Physiol Behav 2010;101: 45–52.

    Article CAS PubMed PubMed Central  Google Scholar 

70. Abegg K, Schiesser M, Lutz TA, Bueter M . Acute peripheral GLP-1 receptor agonism or antagonism does not alter energy expenditure in rats after Roux-en-Y gastric bypass.Physiol Behav 2013;121: 70–78.

    Article CAS PubMed  Google Scholar 

71. Osaka T, Endo M, Yamakawa M, Inoue S . Energy expenditure by intravenous administration of glucagon-like peptide-1 mediated by the lower brainstem and sympathoadrenal system.Peptides 2005;26: 1623–1631.

    Article CAS PubMed  Google Scholar 

72. Heruc GA, Horowitz M, Deacon CF, Feinle-Bisset C, Rayner CK, Luscombe-Marsh Net al. Effects of dipeptidyl peptidase IV inhibition on glycemic, gut hormone, triglyceride, energy expenditure, and energy intake responses to fat in healthy males.Am J Physiol Endocrinol Metab 2014;307: E830–E837.

    Article CAS PubMed  Google Scholar 

73. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG . Central nervous system control of food intake.Nature 2000;404: 661–671.

    Article CAS PubMed  Google Scholar 

74. Asarian L, Geary N . Sex differences in the physiology of eating.Am J Physiol Regul Integr Comp Physiol 2013;305: R1215–R1267.

    Article CAS PubMed PubMed Central  Google Scholar 

75. Eiden S, Daniel C, Steinbrueck A, Schmidt I, Simon E . Salmon calcitonin—a potent inhibitor of food intake in states of impaired leptin signalling in laboratory rodents.J Physiol 2002;541 (Pt 3): 1041–1048.

    Article CAS PubMed PubMed Central  Google Scholar 

76. Osto M, Wielinga PY, Alder B, Walser N, Lutz TA . Modulation of the satiating effect of amylin by central ghrelin, leptin and insulin.Physiol Behav 2007;91: 566–572.

    Article CAS PubMed  Google Scholar 

77. Friedman JM . Leptin, leptin receptors and the control of body weight.Eur J Med Res 1997;2: 7–13.

    CAS PubMed  Google Scholar 

78. Leibel RL . The role of leptin in the control of body weight.Nutr Rev 2002;60 (10 Pt 2): S15–S19.

    Article PubMed  Google Scholar 

79. Myers MG, Cowley MA, Munzberg H . Mechanisms of leptin action and leptin resistance.Annu Rev Physiol 2008;70: 537–556.

    Article CAS PubMed  Google Scholar 

80. Zhang Y, Scarpace PJ . The role of leptin in leptin resistance and obesity.Physiol Behav 2006;88: 249–256.

    Article CAS PubMed  Google Scholar 

81. Roth JD, Roland BL, Cole RL, Trevaskis JL, Weyer C, Koda JEet al. Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies.Proc Natl Acad Sci USA 2008;105: 7257–7262.

    Article CAS PubMed PubMed Central  Google Scholar 

82. Boyle CN, Rossier MM, Lutz TA . Diet-induced obesity, hyperamylinemia and amylin sensitivity.Appetite 2010;54: 636.

    Google Scholar 

83. Boyle CN, Rossier MM, Lutz TA . Influence of high-fat feeding, diet-induced obesity, and hyperamylinemia on the sensitivity to acute amylin.Physiol Behav 2011;104: 20–28.

    Article CAS PubMed  Google Scholar 

84. Trevaskis J, Coffey T, Cole R, Lei C, Wittmer C, Walsh Bet al. Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms.Endocrinology 2008;149: 5679–5687.

    Article CAS PubMed  Google Scholar 

85. Turek VF, Trevaskis JL, Levin BE, Dunn-Meynell AA, Irani B, Gu Get al. Mechanisms of amylin/leptin synergy in rodent models.Endocrinology 2010;151: 143–152.

    Article CAS PubMed  Google Scholar 

86. Seth R, Knight WD, Overton JM . Combined amylin-leptin treatment lowers blood pressure and adiposity in lean and obese rats.Int J Obes 2011;35: 1183–1192.

    Article CAS  Google Scholar 

87. Reidelberger R, Haver A, Chelikani PK, Apenteng B, Perriotte-Olson C, Anders Ket al. Effects of leptin replacement alone and with exendin-4 on food intake and weight regain in weight-reduced diet-induced obese rats.Am J Physiol Endocrinol Metab 2012;302: E1576–E1585.

    Article CAS PubMed PubMed Central  Google Scholar 

88. Zhao S, Kanoski SE, Yan J, Grill HJ, Hayes MR . Hindbrain leptin and glucagon-like-peptide-1 receptor signaling interact to suppress food intake in an additive manner.Int J Obes 2012.

89. Muller TD, Sullivan LM, Habegger K, Yi CX, Kabra D, Grant Eet al. Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21.J Pept Sci 2012;18: 383–393.

    Article CAS PubMed  Google Scholar 

90. Ashwell M, Meade CJ . Obesity: do fat cells from genetically obese mice (C57BL/6J ob/ob) have an innate capacity for increased fat storage?Diabetologia 1978;15: 465–470.

    Article CAS PubMed  Google Scholar 

91. Mack C, Wilson J, Athanacio J, Reynolds J, Laugero K, Guss Set al. Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight.Am J Physiol Regul Integr Comp Physiol 2007;293: R1855–R1863.

    Article CAS PubMed  Google Scholar 

92. Trevaskis JL, Lei C, Koda JE, Weyer C, Parkes DG, Roth JD . Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats.Obesity (Silver Spring) 2010;18: 21–26.

    Article CAS  Google Scholar 

93. Trevaskis JL, Parkes DG, Roth JD . Insights into amylin-leptin synergy.Trends Endocrinol Metab 2010;21: 473–479.

    Article CAS PubMed  Google Scholar 

94. Lutz TA . The interaction of amylin with other hormones in the control of eating.Diabetes Obes Metab 2013;15: 99–111.

    Article CAS PubMed  Google Scholar 

95. Seth R, Terry DE, Parrish B, Bhatt R, Overton JM . Amylin-leptin coadministration stimulates central histaminergic signaling in rats.Brain Res 2012;1442: 15–24.

    Article CAS PubMed  Google Scholar 

96. Moon HS, Chamberland JP, Diakopoulos KN, Fiorenza CG, Ziemke F, Schneider Bet al. Leptin and amylin act in an additive manner to activate overlapping signaling pathways in peripheral tissues;in vitro andex vivo studies in humans.Diabetes Care 2011;34: 132–138.

    Article CAS PubMed  Google Scholar 

97. Moon HS, Chamberland JP, Mantzoros CS . Amylin and leptin activate overlapping signalling pathways in an additive manner in mouse GT1-7 hypothalamic, CC muscle and AML12 liver cell lines.Diabetologia 2012;55: 215–225.

    Article CAS PubMed  Google Scholar 

98. Le Foll C, Johnson MD, Dunn-Meynell A, Boyle CN, Lutz TA, Levin BE . Amylin-induced central IL-6 production enhances ventromedial hypothalamic leptin signaling.Diabetes 2015;64: 1621–1631.

    Article CAS PubMed  Google Scholar 

99. Bhavsar S, Watkins J, Young A . Synergy between amylin and cholecystokinin for inhibition of food intake in mice.Physiol Behav 1998;64: 557–561.

    Article CAS PubMed  Google Scholar 

100. Trevaskis JL, Turek VF, Griffin PS, Wittmer C, Parkes DG, Roth JD . Multi-hormonal weight loss combinations in diet-induced obese rats: therapeutic potential of cholecystokinin?Physiol Behav 2010;100: 187–195.

     Article CAS PubMed  Google Scholar 

101. Lutz TA, Del Prete E, Szabady MM, Scharrer E . Attenuation of the anorectic effects of glucagon, cholecystokinin, and bombesin by the amylin receptor antagonist CGRP(8-37).Peptides 1996;17: 119–124.

     Article CAS PubMed  Google Scholar 

102. Lutz TA, Tschudy S, Rushing PA, Scharrer E . Attenuation of the anorectic effects of cholecystokinin and bombesin by the specific amylin antagonist AC 253.Physiol Behav 2000;70: 533–536.

     Article CAS PubMed  Google Scholar 

103. Mollet A, Meier S, Grabler V, Gilg S, Scharrer E, Lutz TA . Endogenous amylin contributes to the anorectic effects of cholecystokinin and bombesin.Peptides 2003;24: 91–98.

     Article CAS PubMed  Google Scholar 

104. Asarian L, Geary N . Estradiol enhances cholecystokinin-dependent lipid-induced satiation and activates estrogen receptor-alpha-expressing cells in the nucleus tractus solitarius of ovariectomized rats.Endocrinology 2007;148: 5656–5666.

     Article CAS PubMed  Google Scholar 

105. Asarian L, Geary N . Cyclic estradiol treatment phasically potentiates endogenous cholecystokinin’s satiating action in ovariectomized rats.Peptides 1999;20: 445–450.

     Article CAS PubMed  Google Scholar 

106. Thammacharoen S, Lutz TA, Geary N, Asarian L . Hindbrain administration of estradiol inhibits feeding and activates estrogen receptor-alpha-expressing cells in the nucleus tractus solitarius of ovariectomized rats.Endocrinology 2008;149: 1609–1617.

     Article CAS PubMed  Google Scholar 

107. Trevaskis JL, Turek VF, Wittmer C, Griffin PS, Wilson JK, Reynolds JMet al. Enhanced amylin-mediated body weight loss in estradiol-deficient diet-induced obese rats.Endocrinology 2010;151: 5657–5668.

     Article CAS PubMed  Google Scholar 

108. Asarian L, Boyle CN, Lutz TA . Estradiol (E2) increases the acute eating-inhibitory effect of amylin in ovariectomized (OVX) rats.Appetite 2011;57S: S2.

     Article  Google Scholar 

109. Lutz TA . Amylin may offer (more) help to treat postmenopausal obesity.Endocrinology 2011;152: 1–3.

     Article CAS PubMed  Google Scholar 

110. Schwenk RW, Baumeier C, Finan B, Kluth O, Brauer C, Joost HGet al. GLP-1-oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice.Diabetologia 2015;58: 604–614.

     Article CAS PubMed  Google Scholar 

111. Hollander P, Maggs DG, Ruggles JA, Fineman M, Shen L, Kolterman OGet al. Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients.Obes Res 2004;12: 661–668.

     Article CAS PubMed  Google Scholar 

112. Chapman I, Parker B, Doran S, Feinle-Bisset C, Wishart J, Lush CWet al. Low-dose pramlintide reduced food intake and meal duration in healthy, normal-weight subjects.Obesity (Silver Spring) 2007;15: 1179–1186.

     Article CAS  Google Scholar 

113. Aronne L, Fujioka K, Aroda V, Chen K, Halseth A, Kesty NCet al. Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study.J Clin Endocrinol Metab 2007;92: 2977–2983.

     Article CAS PubMed  Google Scholar 

114. Smith SR, Blundell JE, Burns C, Ellero C, Schroeder BE, Kesty NCet al. Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study.Am J Physiol Endocrinol Metab 2007;293: E620–E627.

     Article CAS PubMed  Google Scholar 

115. Smith SR, Aronne LJ, Burns CM, Kesty NC, Halseth AE, Weyer C . Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity.Diabetes Care 2008;31: 1816–1823.

     Article PubMed PubMed Central  Google Scholar 

116. Ravussin E, Smith SR, Mitchell JA, Shringarpure R, Shan K, Maier Het al. Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy.Obesity (Silver Spring) 2009;17: 1736–1743.

     Article CAS  Google Scholar 

117. Bello NT, Kemm MH, Ofeldt EM, Moran TH . Dose combinations of exendin-4 and salmon calcitonin produce additive and synergistic reductions in food intake in nonhuman primates.Am J Physiol Regul Integr Comp Physiol 2010;299: R945–R952.

     Article CAS PubMed PubMed Central  Google Scholar 

118. Rossger K, Charpin-El-Hamri G, Fussenegger M . A closed-loop synthetic gene circuit for the treatment of diet-induced obesity in mice.Nat Commun 2013;4: 2825.

     Article PubMed CAS  Google Scholar 

Download references